SEC Form 4 · accession 0000911916-17-000115
ZIMMER BIOMET HOLDINGS, INC. · ZBH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David C Dvorak
Officer — President and CEO · Director
Period of report
Mar 17, 2017
Accepted (ET)
Mar 21, 2017 · 3:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001136869
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 17, 2017 | M | 23,929 | $0.00 | A | 294,077 | D | |
| Common StockF1 | Mar 17, 2017 | F | 11,151 | $120.47 | D | 282,926 | D | |
| Common StockF2,F3 | Mar 20, 2017 | S | 1,040 | $121.63 | D | 281,886 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF4,F5 | — | Mar 17, 2017 | M | 23,929 | D | — | — | Common Stock | 23,929 | 0 | D |
Explanation of responses
- F1Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units.
- F2Securities sold to cover additional taxes on the vesting of restricted stock units pursuant to a written plan intended to comply with Rule 10b5-1(c)(1) adopted by Mr. Dvorak on September 14, 2016.
- F3Represents the sale of 1,040 shares in multiple transactions, ranging in price from $121.55 to $121.69 per share, resulting in a weighted average sale price of $121.627. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- F4Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.
- F5The earned RSUs vested on March 17, 2017.